These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23672091)

  • 21. New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia.
    Gobbi G; Mirandola P; Tazzari PL; Talarico E; Caimi L; Martini G; Papa S; Conte R; Manzoli FA; Vitale M
    Cytometry B Clin Cytom; 2004 Mar; 58(1):32-8. PubMed ID: 14994373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
    Prechel MM; Jeske WP; Walenga JM
    Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
    Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma vs serum as test sample for the chemiluminescent AcuStar HemosIL HIT-IgG
    Favaloro EJ; Mohammed S
    Int J Lab Hematol; 2021 Feb; 43(1):e41-e44. PubMed ID: 32996703
    [No Abstract]   [Full Text] [Related]  

  • 28. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
    Lo GK; Sigouin CS; Warkentin TE
    Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing for heparin-induced thrombocytopenia antibodies.
    Warkentin TE; Sheppard JA
    Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.
    Selleng K; Warkentin TE; Sheppard JA; Greinacher A
    Transfusion; 2009 Sep; 49(9):1812-8. PubMed ID: 19497062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus.
    Satoh T; Tanaka Y; Okazaki Y; Kaburaki J; Ikeda Y; Kuwana M
    Rheumatology (Oxford); 2012 Sep; 51(9):1721-8. PubMed ID: 22718864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin.
    Amiral J; Peynaud-Debayle E; Wolf M; Bridey F; Vissac AM; Meyer D
    Am J Hematol; 1996 Jun; 52(2):90-5. PubMed ID: 8638647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex.
    Francis JL
    Semin Thromb Hemost; 2004 Jun; 30(3):359-68. PubMed ID: 15282659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M; Saxena R; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combinations of rapid immunoassays for a speedy diagnosis of heparin-induced thrombocytopenia.
    Rittener-Ruff L; Marchetti M; Matthey-Guirao E; Grandoni F; Gomez FJ; Alberio L
    J Thromb Haemost; 2022 Oct; 20(10):2407-2418. PubMed ID: 35808841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISA.
    Radaideh SM; Frenkel EP; Dowell JE; Sarode R; Shen YM
    Clin Appl Thromb Hemost; 2012; 18(2):215-7. PubMed ID: 22067544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
    Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM
    Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure.
    Schönborn L; Esteban O; Wesche J; Dobosz P; Broto M; Puig SR; Fuhrmann J; Torres R; Serra J; Llevadot R; Palicio M; Wang JJ; Gordon TP; Lindhoff-Last E; Hoffmann T; Alberio L; Langer F; Boehme C; Biguzzi E; Grosse L; Endres M; Liman T; Thiele T; Warkentin TE; Greinacher A
    Blood; 2023 Dec; 142(26):2305-2314. PubMed ID: 37883798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens.
    Selleng K; Schütt A; Selleng S; Warkentin TE; Greinacher A
    Transfusion; 2010 Jan; 50(1):32-9. PubMed ID: 19709391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.